Empagmet® 5/500 milligrams
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
MFDS item code 202201367 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication effectively aids in blood sugar control for adult patients with type 2 diabetes in conjunction with dietary and exercise therapy through the combined administration of empagliflozin and metformin. It is particularly used by patients whose blood sugar is not sufficiently controlled and should be used with caution in those with cardiovascular diseases. It helps to improve blood sugar levels and reduce the risk of complications. Patients can expect significant assistance in blood sugar control when taken safely under professional guidance.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is an antidiabetic agent that helps in controlling blood sugar levels. However, caution is necessary due to the potential for a rare side effect called severe lactic acidosis. When taken in combination with other antidiabetic medications, hypoglycemia may occur. Patients with moderate to severe renal impairment, acute kidney issues, serious infections, or heart problems should not take this medication. It should also not be used by women who are pregnant or nursing. Regular kidney function tests should be conducted during treatment to check for abnormalities. Additionally, it may be necessary to temporarily stop taking the medication during gastrointestinal disturbances or dehydration, and serious infections. Side effects such as hypoglycemia, urinary tract infections, genital infections, and increased urination may occur; any unusual symptoms should be reported to a doctor immediately. Elderly patients or those at higher risk of fluid loss should be especially cautious. Alcohol consumption may increase the risk of lactic acidosis and should be avoided during treatment. Before and after surgery or when undergoing imaging tests with iodinated contrast, the medication should be temporarily stopped and should only be resumed after confirming normal kidney function. This medication is not recommended for children, and dosage adjustments should be made for the elderly based on kidney function. In case of an overdose, treatments such as hemodialysis may be required, so caution is advised. Finally, store this medication in a place inaccessible to children and in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity and should be stored in a tightly sealed container. It is best to keep the storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness for a longer period.
Orange-yellow, biconvex, oval film-coated tablets
10 tablets/box [10 tablets/PTP×1], 60 tablets/box [10 tablets/PTP×6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.